With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.34946-82-2,Copper(II) trifluoromethanesulfonate,as a common compound, the synthetic route is as follows.
The complex was prepared according a known procedure [11] , starting from LHMe2 (0.157?g, 1?eq) dissolved in acetone (10?ml) and Et3N (150?mul). A solution of Cu(OTf)2 (0.272?g, 2.1?eq) in acetonitrile (10?ml) was added, and the mixture was stirred for 1?h. The mixture was then concentrated, di-isopropylether (10?ml) was added and the solution was placed at -20?C for 1?week to give the pure complex [Cu2(LMe2)(mu-OH)][OTf] (73?mg, 28%) as a dark solid. ESI-MS (CH3CN), m/z: z?=?1, 589 (M-OTf)+, UV-Vis (CH3CN) (epsilon, M-1?cm-1): 242 (23000), 281 (14000), 326 (16000) 338 (16000), 390 (18000), 760 (185) Anal. Calcd. for C25H27Cu2N6O5S2F3: C, 40.59; H, 3.68; N, 11.36. Found C, 40.62; H, 3.85; N, 11.13.
34946-82-2, As the paragraph descriping shows that 34946-82-2 is playing an increasingly important role.
Reference£º
Article; Gennarini, Federica; Kochem, Amelie; Isaac, James; Mansour, Ali-Taher; Lopez, Isidoro; Le Mest, Yves; Thibon-Pourret, Aurore; Faure, Bruno; Jamet, Helene; Le Poul, Nicolas; Belle, Catherine; Simaan, A. Jalila; Reglier, Marius; Inorganica Chimica Acta; vol. 481; (2018); p. 113 – 119;,
Copper catalysis in organic synthesis – NCBI
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”